You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明康德(02359.HK)預計2020年淨利同比增長50%到60%
格隆匯 01-21 19:33

格隆匯1月21日丨藥明康德(02359.HK)公吿,公司預計2020年年度歸屬於公司股東的淨利潤與2019年年度的人民幣18.55億元相比,增加人民幣9.27億元到人民幣11.12億元,同比增長50%到60%。

公司預計2020年年度實現歸屬於公司股東的扣除非經常性損益的淨利潤與2019年年度的人民幣19.14億元相比,同比增長20%到25%。

公司預計2020年年度經調整的非《國際財務報吿準則》下歸屬於公司股東的淨利潤與2019年年度的人民幣24.07.4億元相比,同比增長45%到50%。

在2020年公司美國區實驗室服務和臨牀合同研究服務(CRO)的收入受到新冠疫情負面影響的情況下,公司中國區實驗室服務和合同研發與生產業務(CDMO)自2020年第二季度起全面恢復正常運營。

2020年下半年,隨着海外客户訂單的增長較快,以及公司產能利用和經營效率的不斷提升,使公司的收入實現強勁增長,與2019年下半年相比漲幅超過30%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account